about
Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutationsTherapies for Prevention and Treatment of Alzheimer's DiseaseDysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseasesOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseDelving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosologyEBI2 regulates intracellular signaling and migration in human astrocyteNuclear Receptor NR1H3 in Familial Multiple SclerosisLoading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterolsSimultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MSPlasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.Oxidative stress and its significant roles in neurodegenerative diseases and cancer.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureDifferential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E).Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.Oxysterol binding protein-related protein 8 mediates the cytotoxicity of 25-hydroxycholesterolRole of copper and cholesterol association in the neurodegenerative process.Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.Arterial, venous and other vascular risk factors in multiple sclerosis.A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway.LXR agonists: new potential therapeutic drug for neurodegenerative diseases.Oxysterol receptors and their therapeutic applications in cancer conditions.Sterols and oxysterols in immune cell function.Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.Esterification of 24S-OHC induces formation of atypical lipid droplet-like structures, leading to neuronal cell death.The oxysterol 27-hydroxycholesterol increases oxidative stress and regulate Nrf2 signaling pathway in astrocyte cells.Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation.The enzyme lecithin-cholesterol acyltransferase esterifies cerebrosterol and limits the toxic effect of this oxysterol on SH-SY5Y cells.Liver X receptors regulate cerebrospinal fluid production.Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.Oxysterols Versus Cholesterol in Model Neuronal Membrane. I. The Case of 7-Ketocholesterol. The Langmuir Monolayer Study.27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation.Quercetin-3-O-(2″-galloyl)-α-L-rhamnopyranoside attenuates cholesterol oxidation product-induced apoptosis by suppressing NF-κB-mediated cell death process in differentiated PC12 cells.Assessment of in vitro removal of cholesterol oxidation products by Lactobacillus casei ATCC334.Oxidative stress and the amyloid beta peptide in Alzheimer's disease.EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination.Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.Comprehensive gene expression analyses of the rat prefrontal cortex after oxysterol treatment.Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
P2860
Q24301033-9B5A29FC-9F8A-4BE1-B1C5-C37CE53DB96FQ26740007-F4065678-11C4-4A25-95AF-9BC8B0711327Q27009984-98A7F03F-1211-4FE1-B9A0-8B81159CE1C8Q27023315-8DD0E1E9-2A16-433D-981A-1F5D4E52D09CQ28081453-936A2BF9-D479-4B02-802E-A07344BD8D17Q28116376-FBBC6C3E-B461-4D8D-B611-89CB91914320Q28276060-B681300B-BD73-45AD-B52B-F1FE9DE76E45Q28538558-A4EBC00A-E6C4-4B18-8763-44AA497F32D2Q28546168-449BD6C3-D020-4267-B4CC-C70D9BBE9C9EQ34039786-C30E2A44-B684-4746-B007-878EF44BF425Q35016411-A89A4F4F-2CCE-4A1E-B7DD-70BAC1A70224Q35078327-CCAF542A-C0A2-4849-B9E0-0AC291B150D6Q35492403-C8FE11E8-39D8-42D0-83FB-3897BD621EACQ35552497-58D5A47F-4809-425C-9207-94C51FA7EB89Q36167749-AF0F92CB-CEBB-4A7B-BF99-682FF49EDAC6Q36641687-90B06F50-FE7A-485C-A367-903A91DD8473Q37282863-86FE0B01-A500-4C41-B5E6-4488B6CE0011Q37316130-B4EDF64F-008F-4ADD-9A47-E95FFB5C424FQ37653212-3EA4299A-58AD-40A3-A123-0FF1B67EDEAFQ38042766-FE553E11-D689-4B16-8F5D-4B4FA7176405Q38098775-4C4A7414-B591-4063-B536-AB4128313365Q38102608-BCF3E643-A78C-4550-9A7B-C820C1D1CA55Q38123210-F51C7B4A-E7EB-43E7-A2D0-B1E011AE1017Q38130108-1078203D-5F8B-4CF8-8D8C-42BFE4F31CD4Q38598430-5F0DB946-1C5D-4C0F-AFB0-D71252D0D39EQ38734322-A2BC8AA3-ACA9-4400-9FE2-A623D8D35A5FQ38915619-30317333-EA3E-4AC8-8C29-4ADF009D1B85Q38973023-54C322FC-56E9-4170-9A27-194B79FF8960Q39016322-812CAB7B-1C89-44C6-88DE-A6F4EC69D6D0Q40589497-11028F66-930F-4BBA-B98D-52AB8D997817Q40759599-6B6C1FE2-2667-491D-90DD-37360A801AD3Q42063617-D29AB01A-A2C6-4FA3-95B9-07D612814AD5Q42317971-322485B5-5AF9-43E6-A573-487DE331B870Q42702100-076258BD-E961-4175-9EDC-2920674854D0Q43806061-10B62582-DF02-4B94-8496-EE4174D4E732Q46272723-1B756FB4-CDE9-471A-8C31-58E40DC52708Q47167898-EB6EE22E-1A38-4DDD-863A-791D12CFAAAFQ47922188-C02EEB85-EFCC-4522-8470-9DA1C12B6146Q48223027-59B30256-FCD9-4FF8-A653-206C320303ACQ49139039-F275F7E2-6FD8-4557-BB76-4462DB873DC2
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oxysterols as biomarkers in neurodegenerative diseases.
@ast
Oxysterols as biomarkers in neurodegenerative diseases.
@en
type
label
Oxysterols as biomarkers in neurodegenerative diseases.
@ast
Oxysterols as biomarkers in neurodegenerative diseases.
@en
prefLabel
Oxysterols as biomarkers in neurodegenerative diseases.
@ast
Oxysterols as biomarkers in neurodegenerative diseases.
@en
P1476
Oxysterols as biomarkers in neurodegenerative diseases.
@en
P2093
Claudio Caccia
Valerio Leoni
P304
P356
10.1016/J.CHEMPHYSLIP.2011.04.002
P577
2011-04-16T00:00:00Z